Држава: Аустралија
Језик: Енглески
Извор: Department of Health (Therapeutic Goods Administration)
cupric chloride dihydrate, Quantity: 560 microgram/mL (Equivalent: copper, Qty 200 microgram/mL); manganese chloride tetrahydrate, Quantity: 740 microgram/mL (Equivalent: copper, Qty 200 microgram/mL; Equivalent: manganese, Qty 200 microgram/mL); chromic chloride hexahydrate, Quantity: 22 microgram/mL (Equivalent: copper, Qty 200 microgram/mL; Equivalent: chromium, Qty 4 microgram/mL)
Phebra Pty Ltd
Injection, intravenous infusion
Excipient Ingredients: water for injections; hydrochloric acid
Intravenous
5mL x 10
Not scheduled. Not considered by committee
INDICATIONS AS AT 01 JANUARY 1991 : This formulation is indicated for use as a supplement to IV solutions given for TPN. Administation of the solution in TPN solutions helps to maintain plasma levels of copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms.
Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 30 degrees Celsius
Registered
1991-10-14